Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.
days to go:
Extended
investment:
£1,014,708
Supermeal is an online food ordering platform offering instant cashback to the customer for every order they place. Supermeal has served more than 50k orders and listed over 100k food items on its portal. The company is signing up 45+ restaurant partners every month with a total of registered 675+ restaurant partners. Supermeal has followed a business model that reduces the fees restaurants pay to 7% and provides a mandatory cashback (5%) to consumers. It has given £11,000+ in cashback and attracted over 10,000 customers generating £53k in device sales and £220,000 in orders. With the proceeds, the company will accelerate its marketing efforts, strengthen its senior management, and operational activities.
days to go:
Expired
investment:
£575,000
RightIndem is a white-label insurance software platform designed to deliver fast claims to claimants on its portal. The company develops and sells its own proprietary cloud-based digital claim process management software ‘as a service’ to the global insurance market. Insurtech is a vast market and attracts large amounts of investment, with $4.36 billion invested in the first three quarters of 2019. Till date, it has contracted clients such as Axa XL, Archipelago, NN Belgium, NN Netherlands, and Mapfre, with engagements at various levels of implementation and progress in the UK, Italy, Peru, US, and South Africa. They have also earned regard for automating claims processes form some of the world’s largest insurance organizations allowing for the settlement of low to mid-value claims within hours instead of days or months. With the proceeds, the company will connect operating expenses to the point where client revenues from claim volumes match operating costs.
days to go:
Expired
investment:
£200,001
Developing ultra-efficient combustion cycles by replacing a conventional engine's mechanical drivetrain with cleaner and compact electrical components. Libertine have created Free Piston Engines that can operate by using either fossil fuels, or renewable energy.
Their products have opportunities to provide benefits in numerous industries and the company has already had discussions with two large automotive firms and OEMs that are interested in utilising the technology. Libertine owns 28 patents and has distributed a license for its product, which is currently generating annual revenue growth of around 90%. Revenues in 2017 totalled £300k.
days to go:
Expired
investment:
£710,970
Genesis technical systems have developed patented technology that enables telecoms operators and services providers a way of delivering faster mobile and fixed broadband services over existing networks at speeds up to 10x faster. The company currently have 27 patents granted and 50 pending in next generation wi fi and internet.
days to go:
Expired
investment:
£3,000,000
Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.
days to go:
Expired
investment:
£388,038
Emission Solutions (EMSOL) empowers organisations to take everyday steps to reduce emissions through their real-time emission monitoring and analytics system. EMSOL's open framework platform is built with networks of sensors like air and noise pollution, vehicle tracking, and working with any asset tags and emission sensors which enables EMSOL to perform real-time measurements with location tags and calibrated sensors. Data from these platforms are easily shared on dashboards, through notifications and gives detailed real-time data on urban noise, air quality, and vehicle pollution. To date, EMSOL won Rushlight Environmental Analysis Award, achieve yearly income targets, rated 5th place in the national PowerUp Index and 4th in the London and South East region. Moreover, EMSOL also won a fully funded project sponsored by DFT to deploy EMSOL technology into the rail sector. The company will use the funds to expand its customer base and increase the number of deployment sites.
days to go:
Expired
investment:
£316,884
The largest built database comprised of residential and commercial properties in the UK, collated from over 500 reputable sources. Nimbus has information for more than 25m leasehold and freehold properties, in addition to 900k unregistered sites, which can all be easily viewed on a digital map. The company expects their current user base of 5.5k to increase to 240k by 2021 and their monthly sales to grow at a similar rate from £92k in April 2018.
days to go:
Expired
investment:
£366,030
Arkivum Limited is a cloud-based Software as a Service (SaaS) that provides specialist digital archiving and preservation services to customers in highly regulated industries, such as pharmaceuticals. Arkivum asserts that its software ensures that the digital content of its customers is safeguarded, usable, and auditable for decades into the future. Arkivum argues that its focus area is archiving clinical trial data for pharmaceutical companies, centring around Electronic Trial Master File (eTMF) that contain tens of thousands of different types of documents and overseen closely by drug sponsors. The company further claims that its services triumph over those offered by Amazon Web Services (AWS), Google Cloud Platform (GCP) and Microsoft Azure. Arkivum points out that its services have led to the company earning £1.4 million as Annual Recurring Revenue (ARR) as of March 2021. Arkivum is seeking to raise up to £1.075 million of equity to grow its business across different verticals.
days to go:
Expired
investment:
Withheld
